FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageans.fr.terminologies
Resource TypeValueSet
IdValueSet-jdv-classe-therapie-cisis.json
FHIR VersionR4
Sourcehttps://interop.esante.gouv.fr/terminologies/1.7.0/ValueSet-jdv-classe-therapie-cisis.html
URLhttps://smt.esante.gouv.fr/fhir/ValueSet/jdv-classe-therapie-cisis
Version20260220142105
Statusactive
Date2026-02-20T14:21:05+01:00
NameJdvClasseTherapieCisis
TitleJDV Classe Therapie CISIS
Realmfr
Authoritynational
DescriptionJDV Classe Therapie CISIS

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1atcWHO Anatomical Therapeutic Chemical classification

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet jdv-classe-therapie-cisis

version: 7; Last updated: 2026-02-23 14:57:51+0100; Language: fr-FR

Profil: Shareable ValueSetversion: null4.0.1)

  • Include ces codes sont définis dans http://www.whocc.no/atc
    CodeDisplay
    L01XXautres antinéoplasiques
    L01Einhibiteurs de protéines kinases
    L01EEinhibiteurs de protéine kinase activée par un mitogène (MEK)
    L01EXautres inhibiteurs de protéines kinases
    L01Fanticorps monoclonaux et conjugués anticorps-médicaments
    L01FXautres anticorps monoclonaux et conjugués anticorps-médicaments

Source1

{
  "resourceType": "ValueSet",
  "id": "jdv-classe-therapie-cisis",
  "meta": {
    "versionId": "7",
    "lastUpdated": "2026-02-23T14:57:51.630+01:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset|4.0.1"
    ]
  },
  "language": "fr-FR",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod",
      "valuePeriod": {
        "start": "2010-01-01T00:00:00+01:00"
      }
    }
  ],
  "url": "https://smt.esante.gouv.fr/fhir/ValueSet/jdv-classe-therapie-cisis",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:1.2.250.1.213.1.1.5.143"
    }
  ],
  "version": "20260220142105",
  "name": "JdvClasseTherapieCisis",
  "title": "JDV Classe Therapie CISIS",
  "status": "active",
  "experimental": false,
  "date": "2026-02-20T14:21:05+01:00",
  "publisher": "Agence du Numérique en Santé(ANS) -2 - 10 Rue d'Oradour-sur-Glane, 75015 Paris",
  "description": "JDV Classe Therapie CISIS",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "FRA"
        }
      ]
    }
  ],
  "compose": {
    "include": [
      {
        "system": "http://www.whocc.no/atc",
        "concept": [
          {
            "code": "L01XX",
            "display": "autres antinéoplasiques"
          },
          {
            "code": "L01E",
            "display": "inhibiteurs de protéines kinases"
          },
          {
            "code": "L01EE",
            "display": "inhibiteurs de protéine kinase activée par un mitogène (MEK)"
          },
          {
            "code": "L01EX",
            "display": "autres inhibiteurs de protéines kinases"
          },
          {
            "code": "L01F",
            "display": "anticorps monoclonaux et conjugués anticorps-médicaments"
          },
          {
            "code": "L01FX",
            "display": "autres anticorps monoclonaux et conjugués anticorps-médicaments"
          }
        ]
      }
    ]
  }
}